Median Technologies SA (EPA: ALMDT)
France
· Delayed Price · Currency is EUR
3.855
-0.120 (-3.02%)
Nov 19, 2024, 5:35 PM CET
Median Technologies Company Description
Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally.
The company offers iBiops, an end-to-end AI-powered technology software as a medical device for early diagnosis of cancers and fibrotic diseases; iSee for image analysis services in clinical trials; and iCRO, which engages in the sale of imaging services for clinical trials in oncology using software.
The company was founded in 2002 and is based in Valbonne, France.
Median Technologies SA
Country | France |
Founded | 2002 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 256 |
CEO | Fredrik Brag |
Contact Details
Address: 1800, Route des CrEtes Valbonne, 06560 France | |
Website | mediantechnologies.com |
Stock Details
Ticker Symbol | ALMDT |
Exchange | Euronext Paris |
Fiscal Year | January - December |
Reporting Currency | EUR |
ISIN Number | FR0011049824 |
SIC Code | 7373 |
Key Executives
Name | Position |
---|---|
Fredrik Brag | Founder, GM, Chief Executive Officer and Director |
Jean-Christophe Montigny | Chief Financial Officer |
Marjorie Kooman | Vice President and Head of Investor and Media Relations |
Emmanuelle Leygues | Head of Corporate and Marketing Communications |
Chrystel Brun | Chief Human Resources Officer |
Ciaran Mark Cooper | Head of Business Development, Clinical Trials Imaging - North America |
Nicolas Dano | Chief Operating Officer of iCRO Business Unit |
Thomas Bonnefont | Chief Operating Officer and Chief Commercial Officer ? eyonis? Business Unit |